USAMRIID | Global Biodefense

Menu

Latest stories

DoD Inspector General to Reevaluate Select Agent Facilities, Biosafety Oversight

US Army Medical Research Institute of Infectious Diseases

Research Halted at USAMRIID Over Biosafety Issues

More on pathogens and preparedness

USAMRIID Seeks Isolation and Purification of Ovatoxins

by Global Biodefense June 15, 2019, 11:12 am
Ology Bioservices Awarded DoD Contract for Countermeasures Against Bioweapons

by Global Biodefense April 15, 2019, 8:16 am
NICBR Winter Symposium on Novel Therapeutics
SIGA, USAMRIID Enter Agreement to Evaluate Post-Exposure Prophylactic for Smallpox

by Global Biodefense October 4, 2018, 3:30 am
Collaboration Among BARDA, DTRA, USAMRIID and Spero to Advance SPR994

by Global Biodefense July 16, 2018, 5:28 am
Biodefense World Summit 2018

by Global Biodefense June 27, 2018, 12:00 am
USAMRIID Temporarily Halts Activity at BSL-3 and BSL-4 Laboratories
USAMRIID Awards Select Agent Research Reagents Contract

by Stephanie Lizotte May 16, 2018, 1:44 am
MIT, USAMRIID Develop Algorithm for Early Warning of Exposure to Pathogens

by Global Biodefense February 27, 2018, 1:39 pm
Monkeypox in Nigeria: The Value of Local Surveillance and Genetic Sequencing

by Global Biodefense February 19, 2018, 1:15 am
USAMRIID-Bavarian Nordic Smallpox Vaccine Phase 3 Study
Enhancing the Efficacy of Adenovirus-5 Vectored Ebola Virus Vaccines

by Global Biodefense May 25, 2017, 9:36 am

Congratulations. You've reached the end of the internet.

Back to Top